Treatment Library
Performance & Recovery

Wolverine

Wolverine is a peptide blend combining BPC-157 and TB-500, commonly discussed as a combined recovery option. It is presented here for educational purposes.

RouteSubcutaneous
CategoryPerformance & Recovery
Clinical StatusEducational / Clinical Review Required

This treatment is presented for educational purposes and is not currently offered through care. Availability is subject to evaluation by a licensed medical provider.

ClearDoseRx branded treatment vial
Treatment Category
Performance & Recovery
Formulation
Subcutaneous injection (compounded)
Route
Subcutaneous
Active Ingredients
Wolverine
Clinical / Regulatory Status
Not FDA-approved as a prescription treatment for any specific condition. Presented for educational purposes.
Monitoring Considerations
Content pending clinical review.

Why people explore this treatment

This treatment is research-oriented and is not FDA-approved as a prescription treatment for any specific condition. The information below reflects how it is commonly discussed in research and wellness contexts.

  • ■Commonly discussed as a combined recovery option
  • ■Studied for potential effects on tissue and muscle recovery

What It Is

Wolverine combines BPC-157 and TB-500, two peptides studied for their potential effects on tissue repair and recovery. The combination is commonly discussed in research and wellness contexts.

How It Works

Research suggests that BPC-157 and TB-500 may influence complementary processes related to tissue repair and recovery. Most available evidence comes from preclinical research, and further human studies are needed.

Clinical Uses

  • ■Commonly discussed as a combined recovery option
  • ■Studied for potential effects on tissue and muscle recovery

Available Formulations

  • ■Subcutaneous injection (compounded)

Potential Benefits

  • ■Content pending clinical review.

Risks & Considerations

  • ■Not FDA-approved as a prescription treatment
  • ■Most evidence from preclinical studies
  • ■Combining peptides may have additional considerations
  • ■Any use should be discussed with a qualified medical provider

Potential Side Effects

  • ■Content pending clinical review.

Who May Not Be a Candidate

  • ■Patients with active malignancy
  • ■Pregnant or breastfeeding women
  • ■Patients with bleeding disorders

Monitoring & Labs

  • ■Content pending clinical review.

Regulatory / Clinical Status

Not FDA-approved as a prescription treatment for any specific condition. Presented for educational purposes.

How It Is Administered

Wolverine has been explored in research settings, typically via subcutaneous injection. Any use should be discussed with a qualified medical provider.

What to Discuss With Your Provider

  • ■Your interest in peptide blends and what you hope to learn
  • ■Your complete medical history and any current injuries or conditions
  • ■All current medications and supplements
  • ■Questions about the current state of research on these peptides

Compare related options

Explore how this treatment relates to other options. No treatment is universally better — your provider can help determine what may be appropriate for your situation.

Frequently Asked Questions

Common questions about this treatment. For personal medical guidance, speak with a licensed provider.

Want to discuss this treatment with a provider?

Start a consultation to discuss whether this treatment or another option may be appropriate for your health goals. Treatment is subject to clinical evaluation and is not guaranteed.

ClearDoseRX

Physician-guided telehealth. Understand your options, explore treatment areas, and connect with licensed medical providers.

ClearDoseRx provides telehealth services. Treatment is subject to evaluation by a licensed medical provider and clinical appropriateness. Nothing on this website constitutes medical advice. Prescription medications are available only when determined appropriate by a licensed provider.

© 2026 ClearDoseRx. All rights reserved.